|
CYM 5541
| S87482-5mg | 5mg | MedMol |
|
Carbamic acid, N-[(1S)-1-[3,4-dihydro-5-methyl-3-(2-methylphenyl)-4-oxo-2-quinazolinyl]ethyl]-, 1,1-dimethylethyl ester
| S87382-1g | 1g | MedMol |
|
Carbamic acid, N-[(1S)-1-methyl-2-[(2-methyl-6-nitrobenzoyl)(2-methylphenyl)amino]-2-oxoethyl]-, 1,1-dimethylethyl ester
| S87383-1g | 1g | MedMol |
|
CarbaMic acid, N-[(1S)-1-(aMinoMethyl)-2-[(3R)-tetrahydro-2H-pyran-3-yl]ethyl]-N-Methyl-, 1,1-diMethylethyl ester
| S87432-100mg | 100mg | MedMol |
|
CarbaMic acid, N-[(1S)-1-(aMinoMethyl)-2-[(3R)-tetrahydro-2H-pyran-3-yl]ethyl]-N-Methyl-, 1,1-diMethylethyl ester
| S87432-250mg | 250mg | MedMol |
|
CarbaMic acid, N-3H-iMidazo[4,5-c]pyridin-4-yl-, 1,1-diMethylethyl ester
| S87370-100mg | 100mg | MedMol |
|
CarbaMic acid, N-3H-iMidazo[4,5-c]pyridin-4-yl-, 1,1-diMethylethyl ester
| S87370-250mg | 250mg | MedMol |
|
CarbaMic acid, N-[(propylaMino)sulfonyl]-, phenylMethyl ester
| S87317-1g | 1g | MedMol |
|
CDDO-EA
| S87353-5mg | 5mg | MedMol |
|
CDDO-EA
| S87353-10mg | 10mg | MedMol |
|
CNV1014802 (hydrochloride)
| S87359-5mg | 5mg | MedMol |
|
CNV1014802 (hydrochloride)
| S87359-10mg | 10mg | MedMol |
|
Cyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1H)-carboxylic acid, 2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro
| S87308-25mg | 25mg | MedMol |
|
CIS-2-CARBOMETHOXYCYCLOPENTANE-1-CARBOXYLIC ACID
| S87315-1g | 1g | MedMol |
|
Carbamic acid, N-[[(2R)-3-(2,2-dimethyl-1-oxopropyl)-5-[(2,2-dimethyl-1-oxopropyl)amino]-2,3-dihydro-2-phenyl-1,3,4-thiadiazol-2
| S87191-1g | 1g | MedMol |
|
Carbamic acid, [3-[5-(2,5-difluorophenyl)-2,3-dihydro-2-phenyl-1,3,4-thiadiazol-2-yl]propyl]-, 1,1-dimethylethyl ester (9CI)
| S87215-500mg | 500mg | MedMol |
|
Cot inhibitor-2
| S87236-5mg | 5mg | MedMol |
|
Cot inhibitor-2
| S87236-10mg | 10mg | MedMol |
|
Cot inhibitor-2
| S87236-25mg | 25mg | MedMol |
|
Cot inhibitor-1
| S87238-5mg | 5mg | MedMol |
|
Cot inhibitor-1
| S87238-10mg | 10mg | MedMol |
|
Cot inhibitor-1
| S87238-25mg | 25mg | MedMol |
|
Carbamic acid, (cyclopropylmethyl)-, 1,1-dimethylethyl ester (9CI)
| S87131-100mg | 100mg | MedMol |
|
Carbamic acid, (cyclopropylmethyl)-, 1,1-dimethylethyl ester (9CI)
| S87131-250mg | 250mg | MedMol |
|
Cligosiban
| S87148-5mg | 5mg | MedMol |
|
Cligosiban
| S87148-10mg | 10mg | MedMol |
|
Carbamic acid, [(1R)-2-[(5-bromo-3-pyridinyl)oxy]-1-(1H-indol-3-ylmethyl)ethyl]-, 1,1-dimethylethyl ester (9CI)
| S87035-25mg | 25mg | MedMol |
|
CyclohexanaMine, 4-[4-(cyclopropylMethyl)-1-piperazinyl]-, (Hydrochloride) , trans-
| S86988-100mg | 100mg | MedMol |
|
CyclohexanaMine, 4-[4-(cyclopropylMethyl)-1-piperazinyl]-, (Hydrochloride) , trans-
| S86988-500mg | 500mg | MedMol |
|
Crizotinib Impurity 23
| S87000-1g | 1g | MedMol |
|
Carbonic acid, 2,4-bis(1,1-dimethylethyl)phenyl methyl ester
| S86957-1g | 1g | MedMol |
|
CarbaMic acid, (4-borono-3-fluorophenyl)-, C-(phenylMethyl) ester (9CI)
| S86966-1g | 1g | MedMol |
|
Carfilzomib intermediate 1
| S86900-1g | 1g | MedMol |
|
Carbamic acid, [(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]-, phenylmethyl ester
| S86847-500mg | 500mg | MedMol |
|
CFMTI
| S86852-1mg | 1mg | MedMol |
|
CFMTI
| S86852-5mg | 5mg | MedMol |
|
CFMTI
| S86852-10mg | 10mg | MedMol |
|
Cytidine, N-benzoyl-2^-deoxy-2^-methylene-,3^,5^-?dibenzoate(9CI)
| S86828-100mg | 100mg | MedMol |
|
Cebranopadol
| S86831-5mg | 5mg | MedMol |
|
Cebranopadol
| S86831-10mg | 10mg | MedMol |
|
Cebranopadol ((1α,4α)stereoisomer)
| S86832-5mg | 5mg | MedMol |
|
Cyclohexanone, 4-hydroxy-4-[5-(2-pyrimidinyl)-2-pyridinyl]-
| S86794-100mg | 100mg | MedMol |
|
Cyclohexanone, 4-hydroxy-4-[5-(2-pyrimidinyl)-2-pyridinyl]-
| S86794-250mg | 250mg | MedMol |
|
Cyclohexanone, 4-hydroxy-4-[5-(2-pyrimidinyl)-2-pyridinyl]-
| S86794-500mg | 500mg | MedMol |
|
Cyclohexanone, 4-hydroxy-4-[5-(2-pyrimidinyl)-2-pyridinyl]-
| S86794-1g | 1g | MedMol |
|
Carbamic acid, [(5S)-5-amino-6-oxo-6-[4-(4-pyridinyl)-1-piperazinyl]hexyl]-, 1,1-dimethylethyl ester, mono[tetrafluoroborate(1-)
| S86821-100mg | 100mg | MedMol |
|
Carbamic acid, [(5S)-5-amino-6-oxo-6-[4-(4-pyridinyl)-1-piperazinyl]hexyl]-, 1,1-dimethylethyl ester, mono[tetrafluoroborate(1-)
| S86821-250mg | 250mg | MedMol |
|
Cyclohexaneacetic acid, α-[(2-pyrazinylcarbonyl)aMino]-, Methyl ester, (αS)-
| S86721-1g | 1g | MedMol |
|
Cevipabulin (TTI-237)
| S86733-5mg | 5mg | MedMol |
|
Cevipabulin (TTI-237)
| S86733-10mg | 10mg | MedMol |
